www.fgks.org   »   [go: up one dir, main page]

WHO/N. Thomas
© Credits

Vaccines and immunization

    Overview

    Immunization is a global health and development success story, saving millions of lives every year. Vaccines reduce risks of getting a disease by working with your body’s natural defences to build protection. When you get a vaccine, your immune system responds.

    We now have vaccines to prevent more than 20 life-threatening diseases, helping people of all ages live longer, healthier lives. Immunization currently prevents 3.5-5 million deaths every year from diseases like diphtheria, tetanus, pertussis, influenza and measles.

    Immunization is a key component of primary health care and an indisputable human right. It’s also one of the best health investments money can buy. Vaccines are also critical to the prevention and control of infectious disease outbreaks. They underpin global health security and will be a vital tool in the battle against antimicrobial resistance.

    Yet despite tremendous progress, vaccination coverage has plateaued in recent years and dropped since 2020. The COVID-19 pandemic and associated disruptions over the past two year have strained health systems, with 25 million children missing out on vaccination in 2021, 6 million more than in 2019 and the highest number since 2009.

    By the end of 2021, nearly all countries had introduced COVID-19 vaccination, and by early 2022 one billion doses of COVID-19 vaccine had been delivered through COVAX.


    Impact

    Vaccines train your immune system to create antibodies, just as it does when it’s exposed to a disease. However, because vaccines contain only killed or weakened forms of germs like viruses or bacteria, they do not cause the disease or put you at risk of its complications.

    Vaccines protect against many different diseases, including:

    • cervical cancer
    • cholera
    • COVID-19
    • diphtheria
    • hepatitis B
    • influenza
    • Japanese encephalitis
    • malaria
    • measles
    • meningitis
    • mumps
    • pertussis
    • pneumonia
    • polio
    • rabies
    • rotavirus
    • rubella
    • tetanus
    • typhoid
    • varicella
    • yellow fever

    Some other vaccines are currently being piloted, including those that protect against Ebola or malaria, but are not yet widely available globally.

    Not all these vaccinations may be needed in your country. Some may only be given prior to travel, in areas of risk, or to people in high-risk occupations. Talk to your healthcare worker to find out what vaccinations are needed for you and your family.
    WHO response

    WHO is working with countries and partners to improve global vaccination coverage, including through these initiatives adopted by the World Health Assembly in August 2020.

    Immunization Agenda 2030

    IA2030 sets an ambitious, overarching global vision and strategy for vaccines and immunization for the decade 2021–2030. It was co-created with thousands of contributions from countries and organizations around the world. It draws on lessons from the past decade and acknowledges continuing and new challenges posed by infectious diseases (e.g. Ebola, COVID-19).

    The strategy has been designed to respond to the interests of every country and intends to inspire and align the activities of community, national, regional and global stakeholders towards achieving a world where everyone, everywhere fully benefits from vaccines for good health and well-being. IA2030 is operationalized through regional and national strategies and a mechanism to ensure ownership and accountability and a monitoring and evaluation framework to guide country implementation.


     

    News

    All →

    Latest publications

    All →
    Considerations for integrating COVID-19 
vaccination into immunization programmes 
and primary health care for 2022 and beyond

    This document lays out key programmatic considerations essential for moving from mass campaigns for COVID-19 vaccination to integrating COVID-19...

    Good practice statement on the use of variant-containing COVID-19 vaccines

    This Good practice statement has been developed on the basis of advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its...

    Communicating with caregivers about the Human Papillomavirus vaccination: facilitator’s guide

    This guide is designed to accompany the training module, Communicating with caregivers about the Human Papillomavirus vaccination: a tool to build confidence...

    Communicating with caregivers about the Human Papillomavirus vaccination: a tool to build confidence in communication skills among health workers

    This training module is designed to equip health workers (‎HWs)‎ with knowledge, skills, confidence and resources to help them in their role to...

    Documents

    All →

    The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their...

    The vaccination session planner is an MS Excel-based tool designed to define the most suitable vaccination session frequency for each service facility,...

    Vaccine Wastage Rates Calculator

    A planning tool for improving the accuracy of forecasting vaccine wastage rates based on service delivery settings. Estimates, with greater precision,...

    MI4A produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk...

    Our work

    Feature stories

    All →

    Infographics

    All →

    Videos

    All →

    Country profiles

    Country profiles present selected data, statistics and information to provide national health profiles at given points in time.
    GO

    Related health topic